Latest Us Market News

Page 16 of 79
Compumedics Limited has reported a robust half-year performance, with revenue climbing 32% to $31 million and a return to profitability, driven by strong MEG system sales and SaaS growth.
Ada Torres
Ada Torres
25 Feb 2026
MyEco Group has reported a 38% improvement in profit before tax and a 51% rise in normalised EBITDA for the first half of FY26, driven by operational restructuring and targeted sales growth. The company’s refreshed leadership team and strategic priorities set the stage for further expansion in sustainable packaging markets.
Victor Sage
Victor Sage
25 Feb 2026
Epiminder Limited has reported a $21.7 million loss for the half-year ending December 2025, alongside a successful $125 million IPO that fuels its commercialisation of the FDA-approved Minder epilepsy monitoring device.
Ada Torres
Ada Torres
25 Feb 2026
Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.
Ada Torres
Ada Torres
25 Feb 2026
Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.
Ada Torres
Ada Torres
24 Feb 2026
Amaero Ltd has announced plans to re-domicile from Australia to the United States, aiming to tap into larger capital markets and position itself for a potential US IPO by late 2026 or early 2027. The move retains its ASX listing while opening doors to broader investor pools and strategic growth opportunities.
Victor Sage
Victor Sage
24 Feb 2026
QuickFee Limited has reported a dramatic turnaround with a $36.45 million profit in H1 FY26, driven by the sale of its US Pay Now business and a strategic capital return to shareholders. Underlying operations show promising growth despite divestments.
Claire Turing
Claire Turing
24 Feb 2026
Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.
Ada Torres
Ada Torres
24 Feb 2026
Fisher & Paykel Healthcare has raised its full-year revenue and profit forecasts for FY26, buoyed by strong hospital product growth and favourable exchange rates, while navigating the complexities of a recent US Supreme Court tariff ruling.
Ada Torres
Ada Torres
23 Feb 2026
Perenti Limited reported steady half-year revenue of $1.73 billion with a 10.9% increase in net profit, underpinned by a $300 million Dalgaranga contract and growing drilling services in the US. The company also announced an unfranked interim dividend and a CEO transition underway.
Maxwell Dee
Maxwell Dee
23 Feb 2026
News Corp will temporarily halt conversions between its Australian and US securities registers around the March 2026 dividend record date to ensure equal treatment of shareholders.
Elise Vega
Elise Vega
20 Feb 2026
Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.
Victor Sage
Victor Sage
20 Feb 2026